Quantum Genomics
is a France-based biopharmaceutical company that develops and commercializes APA inhibitor drugs for the treatment of arterial hypertension and heart failure... Read moreQuantum Genomics
is a France-based biopharmaceutical company that develops and commercializes APA inhibitor drugs for the treatment of arterial hypertension and heart failure... Read more
News
Sep 04, 2024
FinanzNachrichten
Quantum Genomics: QUANTUM GENOMICS: Quantum Genomics reviewed its financial situation and announced that it has filed a declaration of cessation of payment today
Apr 25, 2024
MarketScreener
Quantum Genomics: Quantum Genomics :
Quantum Genomics announces that it has obtained the approval of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of ExactCure's securities.
Mar 13, 2024
centralcharts
Quantum Genomics: Quantum Genomics publishes its results for the 2023 financial year. The merger with ExactCure, which marks the strategic redeployment of the company and will be submiCed for a shareholder vote on April 24.
Dec 14, 2023
MarketScreener
Quantum Genomics: Quantum Genomics :
Quantum Genomics enters into exclusive negotiations with ExactCure
Oct 24, 2023
Marketscreener
Quantum Genomics: Quantum Genomics Socit Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023
Oct 17, 2023
FinanzNachrichten
Quantum Genomics: QUANTUM GENOMICS: Quantum Genomics announces resuming discussions with HealthTech companies following the termination of exclusive negotiations with Vistacare Medical
Jul 20, 2023
FinanzNachrichten
Quantum Genomics: QUANTUM GENOMICS: Quantum Genomics enters into exclusive negotiations with Vistacare Medical with the ambition of creating a reference player in the management of complex wounds
May 26, 2023
FinanzNachrichten
Quantum Genomics: QUANTUM GENOMICS: Quantum Genomics releases its 2022 financial results and provides an update on its MandA discussions
Feb 22, 2023
FinanzNachrichten
Quantum Genomics: QUANTUM GENOMICS: Quantum Genomics announces reorganization of its Board of Directors and staff restructuration in order to focus on new projects
Dec 08, 2022
MarketScreener
Quantum Genomics: Quantum Genomics :
Quantum Genomics gives an update
